Isolation of colistin-resistant Hafnia alvei

Journal of Medical Microbiology

Volumn 58, Issue 2, 2009, Pages 278-280

  Savini, Vincenzo ^a   Catavitello, Chiara ^a   Talia, Marzia ^a   Balbinot, Andrea ^a   Febbo, Fabio ^a   Pompilio, Arianna ^b   Di Bonaventura, Giovanni ^b   Piccolomini, Raffaele ^b   D'Antonio, Domenico ^a  

^a SPIRITO SANTO HOSPITAL   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE AMPC; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIMETHATE; COLISTIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; POLYMYXIN DERIVATIVE; RIFAMPICIN; TETRACYCLINE;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; BURKHOLDERIA PSEUDOMALLEI; CHOLECYSTITIS; CONJUNCTIVITIS; CRITICALLY ILL PATIENT; CROSS RESISTANCE; DISK DIFFUSION; DRUG INDICATION; EDWARDSIELLA TARDA; ENTEROBACTER; FECES CULTURE; GLOMERULUS FILTRATION; HAFNIA ALVEI; HOSPITAL INFECTION; HUMAN; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; LETTER; NEISSERIA; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OTITIS; PERITONITIS; PRIORITY JOURNAL; PROTEUS; PROVIDENCIA; PSEUDOMONAS AERUGINOSA; SALMONELLA; SERRATIA; SKIN INFECTION;

EID: 59949095695     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.001321-0     Document Type: Letter

References (15)

1. Bassetti, M., Repetto, E., Righi, E., Boni, S., Diverio, M., Molinari, M. P., Mussap, M., Artioli, S., Ansaldi, F. & other authors (2008). Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections. J Antimicrob Chemother 61, 417-420.
2. Catchpole, C. R., Andrews, J. M., Brenwald, N. & Wise, R. (1997). A reassessment of the in-vitro activity of colistin sulphomethate sodium. J Antimicrob Chemother 39, 255-260.
3. Gales, A. C., Reis, A. O. & Jones, R. N. (2001). Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39, 183-190.
4. Girlich, D., Naas, T., Bellais, S., Poirel, L., Karim, A. & Nordmann, P. (2000). Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei. Antimicrob Agents Chemother 44, 1470-1478.
5. Janda, J. M. & Abbott, S. L. (2006). The genus Hafnia: from soup to nuts. Clin Microbiol Rev 19,12-18.
6. Jones, R. N., Anderegg, T. R. & Swenson, J. M. the Quality Control Working Group (2005). Quality control guidelines for testing gram- negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods. J Clin Microbiol 43, 925-927.
7. Kasiakou, S. K., Michalopoulos, A., Soteriades, E. S., Samonis, G., Sermaides, G. J. & Falagas, M. E. (2005). Combination therapy with intravenous colistin for management ofinfections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother 49, 3136-3146.
8. Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D. & Coulthard, K. (2005). Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 25, 11-25.
9. Markou, N., Apostolakos, H., Koumoudiou, C., Athanasiou, M., Koutsoukou, A., Alamanos, I. & Gregorakos, L. (2003). Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 7, R78-R83.
10. Muyembe, T., Vandepitte, J. & Desmyter, J. (1973). Natural colistin resistance in Edwardsiella tarda. Antimicrob Agents Chemother 4, 521-524.
11. NCCLS (2003). Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard M2-A8. Wayne, PA: National Committee for Clinical Laboratory Standards.
12. Savini, V., Catavitello, C., Talia, M., Di Berardino, F., Manna, A., Balbinot, A., Febbo, F., Carlino, D., Fioritoni, F. & other authors (2008). Ulcer infection by ESBL-producing Proteus mirabilis: a case report. Int J Low Extrem Wounds 7, 99-101.
13. Shimizu, S., Iyobe, S. & Mitsuhashi, S. (1977). Inducible high resistance to colistin in Proteus strains. Antimicrob Agents Chemother 12, 1-3.
14. Tan, T. Y. & Ng, S. Y. (2006). The in-vitro activity of colistin in gram-negative bacteria. Singapore Med J 47, 621.
15. Thomson, K. S., Sanders, C. C. & Washington, J. A., II (1993). Ceftazidime resistance in Hafnia alvei. Antimicrob Agents Chemother 37, 1375-1376.